Nadine Paillot
Centre Hospitalier Régional de Metz-Thionville · 26 works · 1,042 citations · h-index 7
Top works
- Preoperative Chemotherapy Followed by Surgery Compared With Primary Surgery in Resectable Stage I (Except T1N0), II, and IIIa Non-Small-Cell Lung Cancer
- Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: A randomized trial
- 126 Evaluation of topotecan (Hycamtin™) in relapsed small cell lung cancer (SCLC). A multicentre phase II study
- French phase III trial of preoperative chemotherapy (PCT) in resectable stage I (except T1N0), II, IIIa non-small cell lung cancer (NSCLC)
- Topotecan (Hycamtin™) in small cell lung cancer (SCLC) after failure of first line therapy: Multicentre phase II study
- Etoposide phosphate with carboplatin in the treatment of elderly patients with small-cell lung cancer: A phase II study
- An ongoing randomized study of neoadjuvant chemotherapy in resectable non-small cell lung cancer
- Le cancer bronchique primitif non à petites cellules : analyse des 419 cas de tumeurs T1 (≤ 3 cm) de l’étude KBP-2000-CPHG
- Stratégies thérapeutiques chez les patients opérés pour un carcinome bronchique non à petites cellules. Résultats de l’étude ESCAP-2011-CPHG réalisée par le Collège des pneumologues des hôpitaux généraux (CPHG)
- Vinorelbine (NVB) versus vinorelbine plus cisplatin (NVB-DDP) in advanced non-small cell lung cancer (NSCLC): Results from a randominized clinical trial (240 patients)
- Le sevrage tabagique
- Facteurs prédictifs de survenue d’évènements osseux dans le cancer bronchique
- Tolerability of a combination of carboplatin and etoposide phosphate in elderly patients with small cell lung cancer. A multicentric phase II clinical trial
- 1053 Phase III study of neo-adjuvant chemotherapy in resectable non-small cell lung cancer (NSCLC)
- Gefitinib in heavily pretreated non small cell lung cancer: Results of the expanded access program in Eastern France
- Phase III randomized study of Neo-Adjuvant chemotherapy surgery in non-small cell lung cancer (NSCLC) preliminary results
- ESCAP-2011-CPHG : stratégies thérapeutiques chez les patients opérés d’un cancer bronchique non à petites cellules
- Preliminary results of a randomized study comparing the efficacy of 2 doses of docetaxel 100 mg/m2/3 weeks vs 75 mg/m2/3 weeks in treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) after failure of a previous cis-platin based chemotherapy
- Real-life 2-year therapeutic strategies in the management of 2003 metastatic non-small-cell lung cancers (NSCLCs) in French general hospital.
- Cancer bronchique à petites cellules (CBPC) : étude KBP-2010-CPHG